At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Alpha1-antitrypsin Deficiency Registry
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Mar 25, 2016
In Brief
An observational study for Lung Diseases and 3 related conditions. Completed.
Detailed Summary
To collect data from the 37 participating clinical centers on patients with alpha1-antitrypsin deficiency, including those who received replacement therapy with an intravenous preparation of alpha1-proteinase inhibitor (A1Pi) concentrate.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Emphysema, Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1988
Study CompletionNov 1999
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartSep 1, 1988
Study CompletionNov 1, 1999
TodayJul 2, 2026
Posted 26.1 years ago